Performance Evaluation of PPI Dendrimer Based Valsartan and Fenofibrate Formulations.

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2012, Vol 1, Issue 3

Abstract

The purpose of this investigation was to evaluate the performance of poly (propylene imine) (PPI) dendrimers, with three different drug concentrations, to be used as drug carriers. Drug–dendrimers complexes were investigated for dissolution studies, in vitro drug release studies, and for stability studies. The formation of the complexes between drug molecules and dendrimers were characterized by the FTIR, DSC and SEM spectra of these complexes, showing the appearance of the bond formed between the functional groups of the drug (COOH) and dendrimers (NH2). The drug–dendrimer complexes displayed the controlled release action during in vitro release studies. Pure valsartan (VAL) and fenofibrate (FB) was released in 5 h whereas the PPI dendrimers–VAL-FB complexes released the drug up to 24 h. Formulations with PPI dendrimers were subjected to accelerated stability studies and were found to be most stable in dark, low temperature (0°C) whereas the dark, RT was most suitable storage conditions for formulation with PPI dendrimers.

Authors and Affiliations

P. Sureshkumar*| Nova College of Pharmaceutical Education and Research, Jupudi, Ibrahimpatnam, Krishna District-521456, N. Hematheerthani| Nova College of Pharmaceutical Education and Research, Jupudi, Ibrahimpatnam, Krishna District-521456, J. Vijaya Ratna| Department of Pharmaceutical Sciences, College of Science and Technology, Andhra University, Visakhapatnam-530003

Keywords

Related Articles

A STUYD ON VARIATION OF COELIAC TRUNK BRANCHES IN SOUTH INDIAN POPULATION

A variant course and branching pattern of the coeliac trunk was recorded in a 55-year-old male cadaver during the practical sessions of Basaveshwara medical college, Chitradurga, Karnataka, India. We report on a unique...

FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILMS OF FLUVASTATIN SODIUM BY USING TASTE MASKING TECHNIQUES

Fluvastatin sodium, a HMG-COA reductase inhibitor has shorter half life (1.2). It undergoes extensive first pass metabolism, frequent dosing is required in case of conventional dosage form. It is an bitter drug so an att...

OPTIMIZATION OF RHAMNOLIPID BIOSURFACTNT PRODUCTION BY STREPTOMYCES MATENSIS (NBRC 12889T) USING PLACKETT-BURMAN DESIGN

Surfactants produced by microorganisms are known as biosurfactants. Biosurfactants are becoming important biotechnology products for industrial and medical applications due to their specific modes of action, low toxicity...

Management of Migraine: An Overview

Migraine headache is an episodic headache disorder. Most people who suffer from migraines get headaches that can be quite severe. The pain usually begins in the morning, on one side of the head. The word migraine is deri...

A RARE CASE REPORT OF GIANT CELL TUMOR IN THE BODY OF TALUS AND OUR MANAGEMENT

Giant cell tumor is described as neoplasm of undifferentiated mesenchymal stromal cells with presence of abundant, multi-nucleated giant cells. It is generally considered to be a benign tumor. Giant cell tumor rarely inv...

Download PDF file
  • EP ID EP1573
  • DOI -
  • Views 403
  • Downloads 24

How To Cite

P. Sureshkumar*, N. Hematheerthani, J. Vijaya Ratna (2012). Performance Evaluation of PPI Dendrimer Based Valsartan and Fenofibrate Formulations.. Journal of Biomedical and Pharmaceutical Research, 1(3), 84-91. https://europub.co.uk/articles/-A-1573